Human papillomavirus (HPV) is the most common sexually transmitted infection and a leading cause of cervical cancer and other anogenital malignancies. Our HPV Panel provides comprehensive detection of 14 high-risk HPV genotypes—delivering precise molecular diagnostics for research into HPV epidemiology, cervical cancer screening, and prevention strategies.
Simultaneous detection and genotyping of 14 high-risk HPV types including HPV16 and HPV18 (responsible for ~70% of cervical cancers) plus 12 additional oncogenic genotypes for complete risk stratification.
Note: HPV16 and HPV18 (highlighted in red) are responsible for approximately 70% of all cervical cancer cases worldwide and represent the highest oncogenic risk types.
Validated performance for research and laboratory applications.
Contact our team for pricing, technical specifications, or to request validation data for the HPV Panel.
Request QuoteResearch Use Only (RUO). This product is intended for research use only and is not intended for diagnostic procedures. Not for use in diagnostic procedures in the United States or European Union.